The Tour de France has once again been shrouded in controversy, with the nighttime doping test of Tadej Pogacar sparking intense debate. Remco Evenepoel, the Olympic road and time trial champion, took back-to-back stage wins, reducing Pogacar's overall lead. While Evenepoel's success is commendable, the focus has shifted to the controversial testing methods employed by the ITA drug testing agency.
The ITA's decision to conduct tests on Vingegaard and Pogacar at 2am and 5am, respectively, has been heavily criticized. Some argue that this approach is not in line with the French sports code, which emphasizes strict proportionality between the infringement of athletes' rights and the objectives of the fight against doping. The fact that the judge knew nothing of cycling further adds to the controversy.
Jonathan Vaughters, manager of the EF Education EasyPost team, expressed his concerns, suggesting that the ITA's actions could be seen as a way to justify their existence. He questioned the wisdom of targeting the two fastest riders, especially when they are breaking records in the mountains. Pascal Chanteur, vice-president of the CPA, a professional riders association, also criticized the ITA's nocturnal testing, suggesting that it was due to limited resources rather than a strategic approach.
The lack of positive tests in recent Tours de France has raised suspicions. Christophe Bassons, a former professional rider and whistleblower during the Lance Armstrong era, believes that the absence of positive tests is a red flag. He argues that if testing methods have improved, so have the methods of avoiding detection. This implies that the sport may still be rife with doping, despite the lack of positive tests.
The ITA's director of testing, Olivier Banuls, defended their approach, stating that they are not naive and are doing their best to protect the sport and clean athletes. However, the outcome of the tests remains unknown, leaving the Tour in a state of uncertainty. Pogacar's potential fifth Tour win is clouded by suspicion, and the ITA's testing methods have become a central point of contention.
In my opinion, the ITA's nocturnal testing approach is a double-edged sword. While it may be seen as a necessary measure to combat doping, it also raises questions about the fairness and proportionality of the testing procedures. The lack of transparency and the involvement of judges unfamiliar with cycling only add to the complexity of the situation. As the Tour de France continues, the debate over doping and testing methods will likely persist, leaving a lasting impact on the sport's reputation.
